NYSEAMERICAN : POAS
Phaos Technology Holdings (Cayman) Limited — Key statistics
Healthcare · Medical Devices · Singapore
Last price 1.4 USD (Oct 30, 2026, 9:30 AM EDT) · Market cap 2.95M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.65M |
| Enterprise Value | 2.38M |
Dates
| Measure | Value |
|---|
| Earnings Date | Aug 31, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 1.10M |
| Shares Outstanding | 2.10M |
| Shares Change (YoY) | +23.03% |
| Shares Change (QoQ) | +45.44% |
| Owned by Insiders (%) | 63.53% |
| Owned by Institutions (%) | 2.32% |
| Float | 767,697 |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 25.58 |
| Forward PS | n/a |
| PB Ratio | 0.64 |
| P/TBV Ratio | 0.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 22.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.11 |
| Quick Ratio | 0.64 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -689.71 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -368.99% |
| Return on Assets (ROA) | -91.78% |
| Return on Invested Capital (ROIC) | -112.11% |
| Return on Capital Employed (ROCE) | -116.42% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $10,368 |
| Profits Per Employee | -$483,373 |
| Employee Count | 10 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.27 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 2.31 |
| 200-Day Moving Average | 18.67 |
| Relative Strength Index (RSI) | 33.14 |
| Average Volume (20 Days) | 95,183 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 21,721 |
| Short Previous Month | 28,928 |
| Short % of Shares Out | 1.03% |
| Short % of Float | 2.83% |
| Short Ratio (days to cover) | 0.73 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 103,678 |
| Gross Profit | 13,588 |
| Operating Income | -4.96M |
| Pretax Income | -4.83M |
| Net Income | -4.83M |
| EBITDA | -4.84M |
| EBIT | -4.96M |
| Loss Per Share | -$2.30 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 622,518 |
| Total Debt | 354,055 |
| Net Cash | 268,463 |
| Net Cash Per Share | $0.13 |
| Equity (Book Value) | 4.16M |
| Book Value Per Share | 1.98 |
| Working Capital | 4.02M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -8.53M |
| Capital Expenditures | -31,064 |
| Depreciation & Amortization | 125,796 |
| Net Borrowing | -2.23M |
| Free Cash Flow | -8.56M |
| FCF Per Share | -$4.07 |
Margins
| Measure | Value |
|---|
| Gross Margin | 13.11% |
| Operating Margin | -4,787.10% |
| Pretax Margin | -4,662.25% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -23.03% |
| Shareholder Yield | -23.03% |
| Earnings Yield | -182.26% |
| FCF Yield | -322.70% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 12, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 40.64 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |